|
1
|
Alsina M, Moehler M and Lorenzen S:
Immunotherapy of esophageal cancer: Current status, many trials and
innovative strategies. Oncol Res Treat. 41:266–271. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Dong Z, Wang J, Zhan T and Xu S:
Identification of prognostic risk factors for esophageal
adenocarcinoma using bioinformatics analysis. Onco Targets Ther.
11:4327–4337. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hou J, Zou K, Yang C, Leng X and Xu Y:
Clinicopathological and prognostic significance of circulating
tumor cells in patients with esophageal cancer: A meta-analysis.
Onco Targets Ther. 11:8053–8061. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Hirano H and Kato K: Systemic treatment of
advanced esophageal squamous cell carcinoma: Chemotherapy,
molecular-targeting therapy and immunotherapy. Jpn J Clin Oncol.
49:412–420. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Reichenbach ZW, Murray MG, Saxena R,
Farkas D, Karassik EG, Klochkova A, Patel K, Tice C, Hall TM, Gang
J, et al: Clinical and translational advances in esophageal
squamous cell carcinoma. Adv Cancer Res. 144:95–135.
2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Dong Z, Wang J, Zhang H, Zhan T, Chen Y
and Xu S: Identification of potential key genes in esophageal
adenocarcinoma using bioinformatics. Exp Ther Med. 18:3291–3298.
2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Jamali L, Tofigh R, Tutunchi S, Panahi G,
Borhani F, Akhavan S, Nourmohammadi P, Ghaderian SMH, Rasouli M and
Mirzaei H: Circulating microRNAs as diagnostic and therapeutic
biomarkers in gastric and esophageal cancers. J Cell Physiol.
233:8538–8550. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Li Y, Huang HC, Chen LQ, Xu LY, Li EM and
Zhang JJ: Predictive biomarkers for response of esophageal cancer
to chemo(radio)therapy: A systematic review and meta-analysis. Surg
Oncol. 26:460–472. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Jiang Z, Song Q, Yang S, Zeng R, Li X,
Jiang C, Ding W, Zhang J and Zheng Y: Serum microRNA-218 is a
potential biomarker for esophageal cancer. Cancer Biomark.
15:381–389. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Mei LL, Qiu YT, Zhang B and Shi ZZ:
MicroRNAs in esophageal squamous cell carcinoma: Potential
biomarkers and therapeutic targets. Cancer Biomark. 19:1–9.
2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Correia de Sousa M, Gjorgjieva M, Dolicka
D, Sobolewski C and Foti M: Deciphering miRNAs' action through
miRNA editing. Int J Mol Sci. 20(20)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Mishra S, Yadav T and Rani V: Exploring
miRNA based approaches in cancer diagnostics and therapeutics. Crit
Rev Oncol Hematol. 98:12–23. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kang M, Li Y, Zhu S, Zhang S, Guo S and Li
P: MicroRNA-193b acts as a tumor suppressor gene in human
esophageal squamous cell carcinoma via target regulation of KRAS.
Oncol Lett. 17:3965–3973. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Xia D, Tian S, Chen Z, Qin W and Liu Q:
miR-302a inhibits the proliferation of esophageal cancer cells
through the MAPK and PI3K/Akt signaling pathways. Oncol Lett.
15:3937–3943. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ji KX, Cui F, Qu D, Sun RY, Sun P, Chen
FY, Wang SL and Sun HS: miR-378 promotes the cell proliferation of
non-small cell lung cancer by inhibiting FOXG1. Eur Rev Med
Pharmacol Sci. 22:1011–1019. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Yang H, Su H, Hu N, Wang C, Wang L, Giffen
C, Goldstein AM, Lee MP and Taylor PR: Integrated analysis of
genome-wide miRNAs and targeted gene expression in esophageal
squamous cell carcinoma (ESCC) and relation to prognosis. BMC
Cancer. 20(388)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Edge S, Byrd DR, Compton CC, Fritz AG,
Greene F and Trotti A (eds): AJCC Cancer Staging Manual. 7th
Edition. Springer-Verlag, New York, NY, 2010.
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Goto T, Fujiya M, Konishi H, Sasajima J,
Fujibayashi S, Hayashi A, Utsumi T, Sato H, Iwama T, Ijiri M, et
al: An elevated expression of serum exosomal microRNA-191, - 21,
-451a of pancreatic neoplasm is considered to be efficient
diagnostic marker. BMC Cancer. 18(116)2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Nie X, Su Z, Yan R, Yan A, Qiu S and Zhou
Y: MicroRNA-562 negatively regulated c-MET/AKT pathway in the
growth of glioblastoma cells. Onco Targets Ther. 12:41–49.
2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Lu TX and Rothenberg ME: MicroRNA. J
Allergy Clin Immunol. 141:1202–1207. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Rupaimoole R and Slack FJ: MicroRNA
therapeutics: Towards a new era for the management of cancer and
other diseases. Nat Rev Drug Discov. 16:203–222. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Tomaselli S, Panera N, Gallo A and Alisi
A: Circulating miRNA profiling to identify biomarkers of
dysmetabolism. Biomarkers Med. 6:729–742. 2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhang C, Ji Q, Yang Y, Li Q and Wang Z:
Exosome: Function and role in cancer metastasis and drug
resistance. Technol Cancer Res Treat.
17(1533033818763450)2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lee YS and Dutta A: MicroRNAs in cancer.
Annu Rev Pathol. 4:199–227. 2009.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Vishnoi A and Rani S: MiRNA biogenesis and
regulation of diseases: An overview. Methods Mol Biol. 1509:1–10.
2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Codipilly DC, Qin Y, Dawsey SM, Kisiel J,
Topazian M, Ahlquist D and Iyer PG: Screening for esophageal
squamous cell carcinoma: Recent advances. Gastrointest Endosc.
88:413–426. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Fu JH: Biomarkers of predicting response
to neoadjuvant chemoradiotherapy in esophageal cancer. Zhonghua Wei
Chang Wai Ke Za Zhi. 16:805–810. 2013.PubMed/NCBI(In Chinese).
|
|
30
|
Hou X, Wen J, Ren Z and Zhang G:
Non-coding RNAs: New biomarkers and therapeutic targets for
esophageal cancer. Oncotarget. 8:43571–43578. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Su X, Gao C, Feng X and Jiang M: miR-613
suppresses migration and invasion in esophageal squamous cell
carcinoma via the targeting of G6PD. Exp Ther Med. 19:3081–3089.
2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Yi Y, Lu X, Chen J, Jiao C, Zhong J, Song
Z, Yu X and Lin B: Downregulated miR-486-5p acts as a tumor
suppressor in esophageal squamous cell carcinoma. Exp Ther Med.
12:3411–3416. 2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Li B, Wang Y, Li S, He H, Sun F, Wang C,
Lu Y, Wang X and Tao B: Decreased expression of miR-378 correlates
with tumor invasiveness and poor prognosis of patients with glioma.
Int J Clin Exp Pathol. 8:7016–7021. 2015.PubMed/NCBI
|
|
34
|
Zhang GJ, Zhou H, Xiao HX, Li Y and Zhou
T: miR-378 is an independent prognostic factor and inhibits cell
growth and invasion in colorectal cancer. BMC Cancer.
14(109)2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zeng M, Zhu L, Li L and Kang C: miR-378
suppresses the proliferation, migration and invasion of colon
cancer cells by inhibiting SDAD1. Cell Mol Biol Lett.
22(12)2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Nie X, Xia F, Liu Y, Zhou Y, Ye W, Hean P,
Meng J, Liu H, Liu L, Wen J, et al: Downregulation of Wnt3
suppresses colorectal cancer development through inhibiting cell
proliferation and migration. Front Pharmacol.
10(1110)2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Fei B and Wu H: MiR-378 inhibits
progression of human gastric cancer MGC-803 cells by targeting
MAPK1 in vitro. Oncol Res. 20:557–564. 2012.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Guo XB, Zhang XC, Chen P, Ma LM and Shen
ZQ: miR-378a-3p inhibits cellular proliferation and migration in
glioblastoma multiforme by targeting tetraspanin 17. Oncol Rep.
42:1957–1971. 2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Cui Z, Sun S, Liu Q, Zhou X, Gao S, Peng P
and Li Q: MicroRNA-378-3p/5p suppresses the migration and
invasiveness of oral squamous carcinoma cells by inhibiting KLK4
expression. Biochem Cell Biol. 98:154–163. 2020.PubMed/NCBI View Article : Google Scholar
|
